XW143D7Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
- Billable / Specific Code
XW143D7 is a billable ICD-10-PCS procedure code for Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Transfusion involves putting in blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | W | Anatomical Regions |
| 3 | Operation | 1 | Transfusion |
| 4 | BodyPart | 4 | Central Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | D | High-Dose Intravenous Immune Globulin |
| 7 | Qualifier | 7 | New Technology Group 7 |
Code History
- 30243S1 — Transfuse Nonaut Globulin in Central Vein, Perc
Similar Procedure Codes
Questions About XW143D7
Is XW143D7 a billable code?
Yes. XW143D7 is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XW143D7 mean?
XW143D7 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 4 is the BodyPart (Central Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character D is the Device/Substance/Technology (High-Dose Intravenous Immune Globulin); the 7th character 7 is the Qualifier (New Technology Group 7).
